Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

PRTG - Portage Biotech Inc


IEX Last Trade
3.45
-1.070   -31.014%

Share volume: 195,635
Last Updated: Fri 30 Aug 2024 09:58:11 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology): 0.21%

PREVIOUS CLOSE
CHG
CHG%

$4.52
-1.07
-23.67%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
4%
Profitability 0%
Dept financing 0%
Liquidity 0%
Performance 10%
Performance
5 Days
27.76%
1 Month
-10.25%
3 Months
-32.88%
6 Months
-75.36%
1 Year
-93.52%
2 Year
-97.70%
Key data
Stock price
$3.45
P/E Ratio 
0.00
DAY RANGE
N/A - N/A
EPS 
$0.00
52 WEEK RANGE
$2.10 - $61.99
52 WEEK CHANGE
-$0.93
MARKET CAP 
3.618 M
YIELD 
N/A
SHARES OUTSTANDING 
1.049 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/29/2024
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$451,417
AVERAGE 30 VOLUME 
$187,295
Company detail
CEO:
Region: US
Website: portagebiotech.com
Employees: 2
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services

portage biotech inc is a company based out of canada.

Recent news